Christopher R Defilippi MD
Adult Congenital Heart Disease, Interventional Cardiology
Associate Professor, Medicine, University of Maryland School of Medicine
Join to View Full Profile
3300 Gallows Rd1225Falls Church, VA 22042
Phone+1 703-776-5107
Fax+1 703-776-3751
Dr. Defilippi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Texas Southwestern Medical CenterFellowship, Cardiovascular Disease, 1991 - 1994- University of Texas Southwestern Medical CenterResidency, Internal Medicine, 1989 - 1991
Boston University Medical CenterInternship, Internal Medicine, 1988 - 1989
University of Rochester School of Medicine and DentistryClass of 1988
Certifications & Licensure
MD State Medical License 2000 - 2026
VA State Medical License 2016 - 2026
TX State Medical License 1995 - 2000
American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
- Fellow (FACC) American College of Cardiology
Publications & Presentations
PubMed
- Risks for sudden cardiac and undetermined cause of death among people with HIV in the REPRIEVE primary cardiovascular prevention trial.Christopher deFilippi, Aya Awwad, Gerald S Bloomfield, Isabelle R Weir, Heather Ribaudo
AIDS. 2025-10-01 - Exploring the PREVENT HF score and myocardial function among persons with HIV.Allie R Walpert, Mansi Gupta, Carolyn N Dunderdale, Hanna H Haptu, Monica Manandhar
AIDS. 2025-09-01 - Assessing Benefit in Patients With Heart Failure and Reduced Ejection Fraction: Analysis of the VICTORIA Trial Using Novel Prognostic Risk Stratification.Christopher M O'Connor, Sarah Rathwell, Devan V Mehrotra, Stefano Corda, Ciaran J McMULLAN
Journal of Cardiac Failure. 2025-08-28
Press Mentions
Prognostic Risk in Cardiac Patients Using the Atellica IM High-Sensitivity Troponin I Assay-March 19, 2025March 19th, 2025
High-Sensitivity Troponin T May Offer Glimpse into Future HF Risk: ARIC AnalysisSeptember 13th, 2019
Cardiac Dysfunction Prevalent in Patients with HIVJanuary 30th, 2019- Join now to see all
Grant Support
- The optimal loop diuretic: mechanistic insights from longitudinal changes in blood and urine proteins to explain efficacy and safety of torsemide vs furosemide after a heart failure hospitalizationINOVA HEALTH CARE SERVICES2020–2025
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
